RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges

This publication has 302 references indexed in Scilit:

• Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice
  Molecular Therapy Nucleic Acids, 2012
• Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
  Molecular Therapy Nucleic Acids, 2012
• Efficient In Vivo Delivery of siRNA Into Brain Capillary Endothelial Cells Along With Endogenous Lipoprotein
  Molecular Therapy, 2011
• Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease
  Clinical and Translational Gastroenterology, 2011
• Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease
  Journal of Controlled Release, 2011
• Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon
  Biomaterials, 2011
• Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines
  Nature Materials, 2010
• Transferrin Receptor-Targeted Lipid Nanoparticles for Delivery of an Antisense Oligodeoxyribonucleotide against Bcl-2
  Molecular Pharmaceutics, 2008
• Ultrasound for drug and gene delivery to the brain
  Advanced Drug Delivery Reviews, 2008
• shRNA and siRNA delivery to the brain
  Advanced Drug Delivery Reviews, 2007